189 related articles for article (PubMed ID: 32065870)
1. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients.
Evans RJ; Overholt T; Colaco M; Walker SJ
Can J Urol; 2020 Feb; 27(1):10125-10129. PubMed ID: 32065870
[TBL] [Abstract][Full Text] [Related]
2. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
Gao Y; Liao L
Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Jiang YH; Jhang JF; Lee CL; Kuo HC
Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
[TBL] [Abstract][Full Text] [Related]
4. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
[TBL] [Abstract][Full Text] [Related]
5. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Therapeutic Effect of Intratrigonal Injection of AbobotulinumtoxinA(Dysport) and Hydrodistention in Refractory Interstitial Cystitis /Bladder Pain Syndrome.
Zargham M; Mahmoodi M; Mazdak H; Tadayon F; Mansori M; Kazemi M; Khorami MH; Saberi N
Urol J; 2020 Nov; 18(2):203-208. PubMed ID: 33236337
[TBL] [Abstract][Full Text] [Related]
9. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
10. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome.
Manning J; Dwyer P; Rosamilia A; Colyvas K; Murray C; Fitzgerald E
Int Urogynecol J; 2014 May; 25(5):593-9. PubMed ID: 24276074
[TBL] [Abstract][Full Text] [Related]
11. An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.
Yunfeng G; Fei L; Junbo L; Dingyuan Y; Chaoyou H
Int Urol Nephrol; 2022 Mar; 54(3):479-491. PubMed ID: 35044552
[TBL] [Abstract][Full Text] [Related]
12. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
13. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
14. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
15. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
[TBL] [Abstract][Full Text] [Related]
16. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Frias B; Silva A; Silva JA; Silva CM; Cruz C; Cruz F; Dinis P
Eur Urol; 2010 Sep; 58(3):360-5. PubMed ID: 20227820
[TBL] [Abstract][Full Text] [Related]
17. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Wang HJ; Yu WR; Ong HL; Kuo HC
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Botulinum toxin A for the treatment of Bladder pain syndrome: A systematic review.
Ochoa Vargas DC; García Perdómo HA
Actas Urol Esp (Engl Ed); 2018 Apr; 42(3):152-162. PubMed ID: 28687365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
